ArticleBioinformatics (Oxford, England)2026
Local transcriptional covariation produces accurate estimates of cell phenotype.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
summaryThe utility of single-cell RNA sequencing (scRNA-seq) is premised on the notion that transcriptional state can faithfully reflect cell phenotype. However, scRNA-seq measurements are noisy and sparse, with individual transcript counts showing limited correlation with cell phenotype markers such as protein expression. To better characterize cell states from scRNA-seq data, researchers analyze gene programs-sets of covarying genes-rather than individual transcripts. We hypothesized that more accurate estimation of gene covariation, especially at a local (i.e. cell-state) rather than global (i.e. experimental) scale, could better capture cell phenotypes. However, the field lacks appropriate mathematical frameworks for analyzing gene covariation: coexpression is quantified as a symmetric positive-definite matrix, where even basic operations like arithmetic differences lack biological interpretability. Here, we introduce Sceodesic, which exploits the Riemannian manifold structure of gene coexpression matrices to quantify cell state-specific coexpression patterns using the log-Euclidean metric from differential geometry. Unlike principal components analysis and non-negative matrix factorization, which infer only global covariation, Sceodesic efficiently discovers local covariation patterns and organizes them into interpretable, linear gene programs. Sceodesic outperforms existing approaches in predicting protein expression levels, distinguishing transcriptional responses to gene perturbations, and identifying biologically meaningful programs in fetal development. By respecting the mathematical structure of gene coexpression, Sceodesic bridges the gap between biological variability and statistical analysis of scRNA-seq data, enabling more accurate characterization of cell phenotypes. AVAILABILITY AND IMPLEMENTATION: https://singhlab.net/Sceodesic.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.